AWH Capital’s LeonaBio Inc LONA Stock Holding History

AWH Capital’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,500	Closed	-$351K	–	23
2022 Q2	$351K	Buy	+11,500	New	+$1.05M	0.47%	25

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AWH Capital's LONA Position: Q3 2022 in Review

AWH Capital sold out of LeonaBio Inc (LONA) in Q3 2022, closing a stake of 11,500 shares — an estimated $351K sold.

AWH Capital first reported a position in LONA in Q2 2022 and held it in 1 quarter. The position peaked at $351K in Q2 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q3 2022.

AWH Capital reported no remaining LeonaBio Inc position as of Q3 2022 after selling out during the quarter.
AWH Capital sold 11,500 LeonaBio Inc shares in Q3 2022, an estimated $351K.
AWH Capital first reported a position in LeonaBio Inc in Q2 2022 and held it in 1 quarter.
AWH Capital's LeonaBio Inc position peaked at $351K in Q2 2022.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2022.

Based on AWH Capital's 13F filing for Q3 2022, filed 14 Nov 2022.